Europe Funds Alzheimer's, Brain Aging Systems Bio Consortium | GenomeWeb

NEW YORK (GenomeWeb News) – An international group of collaborators from academia and the business sector will partner to use integrative systems biology and comparative genomics approaches to study age-related human brain diseases with a particular focus on discovering new molecular targets and biomarkers for late-onset Alzheimer's disease.

The AgedBrainSYSBIO project, which is funded with €6 million ($7.7 million) from the European Commission, includes 14 partners in Belgium, France, Estonia, Germany, Israel, the UK, and Switzerland.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.